Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
about
Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohortDrug Repurposing to treat Asthma and Allergic Disorders: Progress and Prospects.Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus.
P2860
Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metformin in severe exacerbati ...... a randomised controlled trial
@en
Metformin in severe exacerbati ...... a randomised controlled trial.
@nl
type
label
Metformin in severe exacerbati ...... a randomised controlled trial
@en
Metformin in severe exacerbati ...... a randomised controlled trial.
@nl
prefLabel
Metformin in severe exacerbati ...... a randomised controlled trial
@en
Metformin in severe exacerbati ...... a randomised controlled trial.
@nl
P2093
P2860
P1433
P1476
Metformin in severe exacerbati ...... a randomised controlled trial
@en
P2093
Emma H Baker
Metformin in COPD Trial Team
Paul W Jones
P2860
P304
P356
10.1136/THORAXJNL-2015-208035
P407
P577
2016-02-25T00:00:00Z